Non-clinical safety assessment of JM-4 to support multiple sclerosis and traumatic brain injury indication.
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $460,936
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR17200214 · Posted Apr 7, 2020
- Contract value 100% obligated
- $460,936.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$88,243 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $549,179 |
About this award
This is a federal contract award to Battelle Memorial Institute (doing business as Battelle), a non-profit research and development organization, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The contract, valued at $460,936.39, is for non-clinical safety assessment of the compound JM-4 to support multiple sclerosis and traumatic brain injury indications.
The contract is a delivery order under the larger "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" master IDIQ contract vehicle. Battelle will provide contract research organization (CRO) support for in vitro and in vivo toxicology studies to NCATS. This includes a sub-award for a 28-day rat toxicology study on JM-4. The contract does not use a set-aside designation.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on August 31, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $460,936 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201700015I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award